Intestinal Microbiota and miRNA in IBD: A Narrative Review about Discoveries and Perspectives for the Future
被引:18
|
作者:
de Oliveira, Ellen Cristina Souza
论文数: 0引用数: 0
h-index: 0
机构:
Sao Paulo State Univ UNESP, Med Sch, Dept Internal Med, Campus Botucatu, BR-18618970 Sao Paulo, BrazilSao Paulo State Univ UNESP, Med Sch, Dept Internal Med, Campus Botucatu, BR-18618970 Sao Paulo, Brazil
de Oliveira, Ellen Cristina Souza
[1
]
Quaglio, Ana Elisa Valencise
论文数: 0引用数: 0
h-index: 0
机构:
Sao Paulo State Univ UNESP, Inst Biosci, Dept Biophys & Pharmacol, Lab Phytomed Pharmacol & Biotechnol PhytoPharmaTec, BR-18618689 Sao Paulo, BrazilSao Paulo State Univ UNESP, Med Sch, Dept Internal Med, Campus Botucatu, BR-18618970 Sao Paulo, Brazil
Quaglio, Ana Elisa Valencise
[2
]
Magro, Daniela Oliveira
论文数: 0引用数: 0
h-index: 0
机构:
State Univ Campinas UNICAMP, Fac Med Sci, Dept Surg, BR-13083970 Campinas, SP, BrazilSao Paulo State Univ UNESP, Med Sch, Dept Internal Med, Campus Botucatu, BR-18618970 Sao Paulo, Brazil
Magro, Daniela Oliveira
[3
]
Di Stasi, Luiz Claudio
论文数: 0引用数: 0
h-index: 0
机构:
Sao Paulo State Univ UNESP, Inst Biosci, Dept Biophys & Pharmacol, Lab Phytomed Pharmacol & Biotechnol PhytoPharmaTec, BR-18618689 Sao Paulo, BrazilSao Paulo State Univ UNESP, Med Sch, Dept Internal Med, Campus Botucatu, BR-18618970 Sao Paulo, Brazil
Di Stasi, Luiz Claudio
[2
]
Sassaki, Ligia Yukie
论文数: 0引用数: 0
h-index: 0
机构:
Sao Paulo State Univ UNESP, Med Sch, Dept Internal Med, Campus Botucatu, BR-18618970 Sao Paulo, BrazilSao Paulo State Univ UNESP, Med Sch, Dept Internal Med, Campus Botucatu, BR-18618970 Sao Paulo, Brazil
Sassaki, Ligia Yukie
[1
]
机构:
[1] Sao Paulo State Univ UNESP, Med Sch, Dept Internal Med, Campus Botucatu, BR-18618970 Sao Paulo, Brazil
[2] Sao Paulo State Univ UNESP, Inst Biosci, Dept Biophys & Pharmacol, Lab Phytomed Pharmacol & Biotechnol PhytoPharmaTec, BR-18618689 Sao Paulo, Brazil
[3] State Univ Campinas UNICAMP, Fac Med Sci, Dept Surg, BR-13083970 Campinas, SP, Brazil
Inflammatory bowel disease (IBD) includes Crohn's disease (CD) and ulcerative colitis (UC) and comprises a chronic gastrointestinal tract disorder characterized by hyperactive and dysregulated immune responses to environmental factors, including gut microbiota and dietary components. An imbalance of the intestinal microbiota may contribute to the development and/or worsening of the inflammatory process. MicroRNAs (miRNAs) have been associated with various physiological processes, such as cell development and proliferation, apoptosis, and cancer. In addition, they play an important role in inflammatory processes, acting in the regulation of pro- and anti-inflammatory pathways. Differences in the profiles of miRNAs may represent a useful tool in the diagnosis of UC and CD and as a prognostic marker in both diseases. The relationship between miRNAs and the intestinal microbiota is not completely elucidated, but recently this topic has gained prominence and has become the target of several studies that demonstrate the role of miRNAs in the modulation of the intestinal microbiota and induction of dysbiosis; the microbiota, in turn, can regulate the expression of miRNAs and, consequently, alter the intestinal homeostasis. Therefore, this review aims to describe the interaction between the intestinal microbiota and miRNAs in IBD, recent discoveries, and perspectives for the future.